Affiliation:
1. Instituto Nacional de Câncer, Coordenação de Pesquisa,1 and
2. Unidade de Farmacologia Clı́nica, Santa Casa da Misericórdia,2 Rio de Janeiro, Brazil
Abstract
ABSTRACT
Amoxicillin plasma concentrations (
n
= 1,152) obtained from 48 healthy subjects in two bioequivalence studies were used to develop limited-sampling strategy (LSS) models for estimating the area under the concentration-time curve (AUC), the maximum concentration of drug in plasma (
C
max
), and the time interval of concentration above MIC susceptibility breakpoints in plasma (T>MIC). Each subject received 500-mg amoxicillin, as reference and test capsules or suspensions, and plasma concentrations were measured by a validated microbiological assay. Linear regression analysis and a “jack-knife” procedure revealed that three-point LSS models accurately estimated (
R
2
, 0.92; precision, <5.8%) the AUC from 0 h to infinity (AUC
0-∞
) of amoxicillin for the four formulations tested. Validation tests indicated that a three-point LSS model (1, 2, and 5 h) developed for the reference capsule formulation predicts the following accurately (
R
2
, 0.94 to 0.99): (i) the individual AUC
0-∞
for the test capsule formulation in the same subjects, (ii) the individual AUC
0-∞
for both reference and test suspensions in 24 other subjects, and (iii) the average AUC
0-∞
following single oral doses (250 to 1,000 mg) of various amoxicillin formulations in 11 previously published studies. A linear regression equation was derived, using the same sampling time points of the LSS model for the AUC
0-∞
, but using different coefficients and intercept, for estimating
C
max
. Bioequivalence assessments based on LSS-derived AUC
0-∞
's and
C
max
's provided results similar to those obtained using the original values for these parameters. Finally, two-point LSS models (
R
2
= 0.86 to 0.95) were developed for T>MICs of 0.25 or 2.0 μg/ml, which are representative of microorganisms susceptible and resistant to amoxicillin.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference26 articles.
1. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination
2. Agência Nacional de Vigilância Sanitária
Resolução 391/99. Diário Oficial da União Brası́lia
1999
318
330
Agência Nacional de Vigilância Sanitária
Brası́lia Brazil
3. Simple analysis of amoxycillin in plasma by high performance liquid chromatography with internal standardization and ultraviolet detection.;Charles B.;Biomed. Chromatogr.,1993
4. EPUC
Dicionário de Especialidades Farmacêuticas. Jornal Brasileiro de Medicina
1999
173
174
EPUC
Sao Paulo Brazil
5. Regressions by leaps and bounds.;Furnival G. M.;Technometrics,1974
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献